Leon Goldstein, MD
Plastic Surgery · Madison, CTNPI 1285642595
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by LEO Pharma Inc. at 30.4% of the total. That places this record below the midpoint for plastic surgery clinicians in CT, where the typical reported total is $989.
Across 28 payments — averaging $25.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma Inc.$221
- Incyte Corporation$125
- UCB, Inc.$92
- AbbVie$75
- Regeneron Healthcare Solutions, Inc.$65
- E.r. Squibb & Sons, L.L.C.$54
- plus $94 from 4 others
What the payments were for
- Food & beverage$726100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma Inc. | 8 | $221 |
| Incyte Corporation | 5 | $125 |
| UCB, Inc. | 3 | $92 |
| AbbVie | 3 | $75 |
| Regeneron Healthcare Solutions, Inc. | 2 | $65 |
| E.r. Squibb & Sons, L.L.C. | 2 | $54 |
| Sun Pharmaceutical Industries Inc. | 2 | $32 |
| Mylan Institutional Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Merz North America, Inc. | 1 | $17 |
How this compares
$726 in reported general payments places this provider in the 40th percentile of 62 plastic surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 13 | $24 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Madison
- Michael AlperovichNew Haven$78K
- Derek SteinbacherGuilford$59K
- Siba HaykalNew Haven$45K
- Wilfred BrownMiddlebury$34K
- Beth CollinsGuilford$29K
- Stephen BrownHartford$17K
- Gary RussolilloWest Hartford$15K
- Melissa MastroianniFairfield$14K
- Patrick FeliceBloomfield$13K
- Leif NordbergStamford$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.